Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial

TY - JOUR

T1 - Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial

AU - Diaz, John Paul

AU - Gatcliffe, Troy

AU - Diaz, Zuanel

AU - Schroeder, Eric

AU - Lambrou, Nicholas

AU - Eiseler, Nicole

AU - Morrissey, Thomas

N1 - Gynecologic Oncology (2021) 162:S66-S67

PY - 2021/8/1

Y1 - 2021/8/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4206

M3 - Article

VL - 162

JO - Gynecologic Oncology

JF - Gynecologic Oncology

ER -